Status:
COMPLETED
Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Pregnancy
Neonates
Eligibility:
FEMALE
18-39 years
Brief Summary
The objective of this trial was to evaluate whether Org 36286 treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) for in vitro fertilization ...
Detailed Description
This was an open, prospective follow-up trial to monitor pregnancy, delivery, and neonatal outcome of women who became pregnant during Trial 38826. For this trial, no study specific assessments were r...
Eligibility Criteria
Inclusion
- Subjects who participated in Trial 38826 and became pregnant (as confirmed by USS at or beyond 10 weeks after ET) after having received at least one dose of either Org 36286 or Puregon®; and
- Able and willing to give written informed consent.
Exclusion
- None
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2005
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00702988
Start Date
October 1 2003
End Date
February 28 2005
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.